Agree. Company needs to start delivering now otherwise nost likely SP will reach 0.10 .
I am honestly struggling to understand how can company spend about $2.5 million a quarter. It will be appreciated if anyone can share a proper breakdown of each category.
If there is no update from company about FDA De Nova and 510K application progress by March. I am happy to sell all my holding and move on with my losses.
CFO and Company Controller is gone. Who is looking after financials ?
Ann: Medibio Quarterly Update and Cashflow Report, page-14
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.140M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 498 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 499 | 1 |
View Market Depth
| Last trade - 07.58am 30/09/2024 (20 minute delay) ? |
| TRI (ASX) Chart |
Day chart unavailable